Insider · CIK 0001746636

Pendleton Todd

Reports to the SEC for 1 company · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001746636

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-22	DLBDolby Laboratories, Inc.S Sale	SVP, Chief Marketing Officer	SSale	−11.9K sh	$54.55	−$648K	41,480
2025-12-16	DLBDolby Laboratories, Inc.F Tax Payment	SVP, Chief Marketing Officer	FTax Payment	−1,959 sh	$66.62	−$131K	53,356
2025-12-15	DLBDolby Laboratories, Inc.A Award	SVP, Chief Marketing Officer	AAward	+18.8K sh	—	—	56,138
2025-12-15	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+5,233 sh	—	—	61,371
2025-12-15	DLBDolby Laboratories, Inc.F Tax Payment	SVP, Chief Marketing Officer	FTax Payment	−6,056 sh	$67.54	−$409K	55,315
2025-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	SVP, Chief Marketing Officer	AAward	+9,424 sh	—	—	9,424
2025-12-15	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	SVP, Chief Marketing Officer	AAward	+41.5K sh	—	—	41,500
2025-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	−5,233 sh	—	—	0
2025-02-19	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+7,286 sh	$71.07	+$518K	55,411
2025-02-19	DLBDolby Laboratories, Inc.S Sale	SVP, Chief Marketing Officer	SSale	−18.1K sh	$83.75	−$1.52M	37,290
2025-02-19	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	−7,286 sh	—	—	13,358
2024-12-16	DLBDolby Laboratories, Inc.A Award	SVP, Chief Marketing Officer	AAward	+15.6K sh	—	—	51,244
2024-12-16	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+4,593 sh	—	—	55,837
2024-12-16	DLBDolby Laboratories, Inc.F Tax Payment	SVP, Chief Marketing Officer	FTax Payment	−7,712 sh	$79.18	−$611K	48,125
2024-12-16	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	SVP, Chief Marketing Officer	AAward	+7,775 sh	—	—	7,775
2024-12-16	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	SVP, Chief Marketing Officer	AAward	+27.3K sh	—	—	27,334
2024-12-16	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	−4,593 sh	—	—	0
2024-02-28	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+8,499 sh	$71.07	+$604K	56,566
2024-02-28	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+3,523 sh	$68.40	+$241K	60,089
2024-02-28	DLBDolby Laboratories, Inc.S Sale	SVP, Chief Marketing Officer	SSale	−24.4K sh	$81.69	−$1.99M	35,694
2024-02-28	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	−8,499 sh	—	—	20,644
2024-02-28	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	−3,523 sh	—	—	0
2023-12-18	DLBDolby Laboratories, Inc.F Tax Payment	SVP, Chief Marketing Officer	FTax Payment	−1,153 sh	$87.49	−$101K	48,067
2023-12-15	DLBDolby Laboratories, Inc.A Award	SVP, Chief Marketing Officer	AAward	+13.8K sh	—	—	50,818
2023-12-15	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+5,118 sh	—	—	55,936
2023-12-15	DLBDolby Laboratories, Inc.F Tax Payment	SVP, Chief Marketing Officer	FTax Payment	−6,716 sh	$88.60	−$595K	49,220
2023-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	SVP, Chief Marketing Officer	AAward	+6,921 sh	—	—	6,921
2023-12-15	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	SVP, Chief Marketing Officer	AAward	+24.3K sh	—	—	24,262
2023-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	−5,118 sh	—	—	0
2023-08-31	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+5,285 sh	$68.40	+$361K	43,865
2023-08-31	DLBDolby Laboratories, Inc.S Sale	SVP, Chief Marketing Officer	SSale	−6,889 sh	$84.41	−$581K	36,976
2023-08-31	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	−5,285 sh	—	—	3,523
2023-02-22	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+5,250 sh	$64.60	+$339K	54,145
2023-02-22	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+5,209 sh	$62.43	+$325K	59,354
2023-02-22	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+7,927 sh	$68.40	+$542K	67,281
2023-02-22	DLBDolby Laboratories, Inc.S Sale	SVP, Chief Marketing Officer	SSale	−28.7K sh	$82.32	−$2.36M	38,580
2023-02-22	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	−5,250 sh	—	—	0
2023-02-22	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	−5,209 sh	—	—	0
2023-02-22	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	−7,927 sh	—	—	8,808
2022-12-19	DLBDolby Laboratories, Inc.F Tax Payment	SVP, Chief Marketing Officer	FTax Payment	−1,116 sh	$70.80	−$79K	48,895
2022-12-16	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+3,765 sh	—	—	53,031
2022-12-16	DLBDolby Laboratories, Inc.F Tax Payment	SVP, Chief Marketing Officer	FTax Payment	−3,020 sh	$71.07	−$215K	50,011
2022-12-16	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	−3,765 sh	—	—	0
2022-12-15	DLBDolby Laboratories, Inc.F Tax Payment	SVP, Chief Marketing Officer	FTax Payment	−3,197 sh	$73.17	−$234K	33,078
2022-12-15	DLBDolby Laboratories, Inc.A Award	SVP, Chief Marketing Officer	AAward	+16.2K sh	—	—	49,266
2022-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	SVP, Chief Marketing Officer	AAward	+8,094 sh	—	—	8,094
2022-12-15	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	SVP, Chief Marketing Officer	AAward	+29.1K sh	—	—	29,143
2022-07-18	DLBDolby Laboratories, Inc.F Tax Payment	SVP, Chief Marketing Officer	FTax Payment	−1,513 sh	$73.09	−$111K	36,275
2022-05-19	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP, Chief Marketing Officer	MExercise/Conversion	+5,813 sh	$68.40	+$398K	43,601
2022-05-19	DLBDolby Laboratories, Inc.S Sale	SVP, Chief Marketing Officer	SSale	−5,813 sh	$75.80	−$441K	37,788

Recent filings

Accepted (ET)
May 274
Pendleton Todd0001193125-26-242141
SEC(opens sec.gov)
Dec 174
Pendleton Todd0001193125-25-323435
SEC(opens sec.gov)
Feb 214
Pendleton Todd0000950170-25-024984
SEC(opens sec.gov)
Dec 184
Pendleton Todd0000950170-24-138167
SEC(opens sec.gov)
Mar 14
Pendleton Todd0000950170-24-023922
SEC(opens sec.gov)

Companies

Dolby Laboratories, Inc.SVP, Chief Marketing OfficerDLB

Address

C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET

SAN FRANCISCO, CA, 94103